The DOI matches its Crossref record; 248 of the 248 references it cites were found in a registry or an index.
Functions of NOD-Like Receptors in Human Diseases
Open accessAbstract
Nucleotide-binding and oligomerization domain NOD-like receptors (NLRs) are highly conserved cytosolic pattern recognition receptors that perform critical functions in surveying the intracellular environment for the presence of infection, noxious substances, and metabolic perturbations. Sensing of these danger signals by NLRs leads to their oligomerization into large macromolecular scaffolds and the rapid deployment of effector signaling cascades to restore homeostasis. While some NLRs operate by recruiting and activating inflammatory caspases into inflammasomes, others trigger inflammation via alternative routes including the nuclear factor-κB, mitogen-activated protein kinase, and regulatory factor pathways. The critical role of NLRs in development and physiology is demonstrated by their clear implications in human diseases. Mutations in the genes encoding NLRP3 or NLRP12 lead to hereditary periodic fever syndromes, while mutations in CARD15 that encodes NOD2 are linked to Crohn's disease or Blau's syndrome. Genome-wide association studies (GWASs) have identified a number of risk alleles encompassing NLR genes in a host of diseases including allergic rhinitis, multiple sclerosis, inflammatory bowel disease, asthma, multi-bacillary leprosy, vitiligo, early-onset menopause, and bone density loss in elderly women. Animal models have allowed the characterization of underlying effector mechanisms in a number of cases. In this review, we highlight the functions of NLRs in health and disease and discuss how the characterization of their molecular mechanisms provides new insights into therapeutic strategies for the management of inflammatory pathologies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–248 of 248
Pereira, M. S. F., Morgantetti, G. F., Massis, L. M., Horta, C. V., Hori, J. I., & Zamboni, D. S. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003784 · Cited by 96
Common Polymorphisms in theNOD2Gene Region Are Associated with Leprosy and Its Reactive States
Berrington, W. R., Macdonald, M., Khadge, S., Sapkota, B. R., Janer, M., Hagge, D. A., Kaplan, G., & Hawn, T. R. (2010) · The Journal of Infectious Diseases · doi:10.1086/651559 · Cited by 96
Dieudé, P., Guedj, M., Wipff, J., Ruiz, B., Riemekasten, G., Airo, P., Melchers, I., HACHULLA, E., Matucci‐Cerinic, M., Diot, É., et al. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.131243 · Cited by 95
A coding variant in NLRP1 is associated with autoimmune Addison's disease
Żurawek, M., Fichna, M., Januszkiewicz‐Lewandowska, D., Gryczyńska, M., Fichna, P., & Nowak, J. (2010) · Human Immunology · doi:10.1016/j.humimm.2010.02.004 · Cited by 93
NLRX1 does not inhibit MAVS-dependent antiviral signalling
Soares, F., Tattoli, I., Wortzman, M. E., Arnoult, D., Philpott, D. J., & Girardin, S. E. (2012) · Innate Immunity · doi:10.1177/1753425912467383 · Cited by 92
CK1ε Is Required for Breast Cancers Dependent on β-Catenin Activity
Kim, S. Y., Dunn, I. F., Firestein, R., Gupta, P. B., Wardwell, L., Repich, K., Schinzel, A. C., Wittner, B. S., Silver, S. J., Root, D. E., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008979 · Cited by 90
Uehara, A., Imamura, T., Potempa, J., Travis, J. W., & Takada, H. (2008) · Cellular Microbiology · doi:10.1111/j.1462-5822.2008.01119.x · Cited by 89
NOD1 and NOD2 regulation of pulmonary innate immunity to Legionella pneumophila
Berrington, W. R., Iyer, R. F., Wells, R. D., Smith, K. D., Skerrett, S. J., & Hawn, T. R. (2010) · European Journal of Immunology · doi:10.1002/eji.201040518 · Cited by 83
Programmed necrosis and autophagy in immune function
Lu, J. V., & Walsh, C. M. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2012.01147.x · Cited by 83
The NLR protein, NLRX1, and its partner, TUFM, reduce type I interferon, and enhance autophagy
Lei, Y. L., Wen, H., & Ting, J. P. ‐. (2013) · Autophagy · doi:10.4161/auto.23026 · Cited by 80
A Common Genetic Fingerprint in Leprosy and Crohn's Disease?
Schurr, E., & Gros, P. (2009) · New England Journal of Medicine · doi:10.1056/nejme0910690 · Cited by 78
Marriott, I., Rati, D. M., McCall, S. H., & Tranguch, S. L. (2005) · Infection and Immunity · doi:10.1128/iai.73.5.2967-2973.2005 · Cited by 77
NLRX1/NOD5 deficiency does not affect MAVS signalling
Rebsamen, M., Vázquez, J., Tardivel, A., Guarda, G., Curran, J. A., & Tschopp, J. (2011) · Cell Death and Differentiation · doi:10.1038/cdd.2011.64 · Cited by 74
Lipinski, S., Grabe, N., Jacobs, G., Billmann-Born, S., Till, A., Häsler, R., Aden, K., Paulsen, M., Arlt, A., Kraemer, L., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1209673109 · Cited by 72
Messaed, C., Akoury, E., Djuric, U., Zeng, J., Saleh, M., Gilbert, L., Seoud, M. A.-F., Qureshi, S. T., & Slim, R. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.306191 · Cited by 71
Self-citationEvaluation of Nod-Like Receptor (NLR) Effector Domain Interactions
Wagner, R. N., Proell, M., Kufer, T. A., & Schwarzenbacher, R. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004931 · Cited by 70
Cressman, D. E., O’Connor, W. J., Greer, S. F., Zhu, X., & Ting, J. P. ‐. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.7.3626 · Cited by 70
Ashton, K. A., Proietto, A. M., Otton, G. R., Symonds, I., McEvoy, M., Attia, J., Gilbert, M. B., Hamann, U., & Scott, R. J. (2010) · Cancer Epidemiology · doi:10.1016/j.canep.2010.03.005 · Cited by 68
Allen, I. C., McElvania, E., Wilson, J. E., Lich, J. D., Arthur, J. C., Sullivan, J. T., Braunstein, M., & Ting, J. P. ‐. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060842 · Cited by 67
LEJEUNE, J. (1981) · PubMed · Cited by 67
Role of the MHC2TA gene in autoimmune diseases
Martínez, A., Sánchez-López, M., Varadé, J., Mas, A. I. R., Martín, M. C., Heras, V. D. L., Arroyo, R., Mendoza, J. L., Díaz‐Rubio, M., Fernández‐Gutiérrez, B., et al. (2006) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.059428 · Cited by 65
Joly, S., Eisenbarth, S. C., Olivier, A. K., Williams, A., Kaplan, D. H., Cassel, S. L., Flavell, R. A., & Sutterwala, F. S. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1201715 · Cited by 65
Vieira, S. M., Cunha, T. M., França, R. F. D. O., Pinto, L. G., Talbot, J., Turato, W. M., Lemos, H. D. P., Lima, J. B., Verri, W. A., Jr., Almeida, S. C. L., et al. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1004190 · Cited by 64
Lewis, G. J., Massey, D. C. O., Zhang, H., Bredin, F., Tremelling, M., Lee, J. C., Berzuini, C., & Parkes, M. (2010) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21499 · Cited by 60
Soler, V. J., Tran-Viet, K.-N., Galiacy, S. D., Limviphuvadh, V., Klemm, T., St.Germain, E., Fournié, P., Guillaud, C., Maurer‐Stroh, S., Hawthorne, F. A., et al. (2013) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2012-101325 · Cited by 58
Jamilloux, Y., Pierini, R., Querenet, M., Juruj, C., Fauchais, A. L., Jauberteau, M., Jarraud, S., Lina, G., Étienne, J., Roy, C. R., et al. (2013) · Glia · doi:10.1002/glia.22454 · Cited by 54
NLRP10 enhancesShigella-induced pro-inflammatory responses
Lautz, K., Damm, A., Menning, M., Wenger, J., Adam, A. C., Zigrino, P., Kremmer, E., & Kufer, T. A. (2012) · Cellular Microbiology · doi:10.1111/j.1462-5822.2012.01822.x · Cited by 52
de Jesus, A. A., Silva, C. A., Segundo, G. R. S., et al. (2007) · Journal of Clinical Immunology · doi:10.1007/s10875-007-9150-7 · Cited by 50
Monarch-1/PYPAF7 and other CATERPILLER (CLR, NOD, NLR) proteins with negative regulatory functions
Lich, J. D., & Ting, J. P.-Y. (2007) · Microbes and Infection · doi:10.1016/j.micinf.2007.01.018 · Cited by 48
Oncogenic role of NALP7 in testicular seminomas
Okada, K., Hirota, E., Mizutani, Y., Fujioka, T., Shuin, T., Miki, T., Nakamura, Y., & Katagiri, T. (2004) · Cancer Science · doi:10.1111/j.1349-7006.2004.tb03182.x · Cited by 44
Loving, C. L., Osorio, M., Kim, Y., Núñez, G., Hughes, M. A., & Merkel, T. J. (2009) · Infection and Immunity · doi:10.1128/iai.00563-09 · Cited by 43
Imagawa, T., Nishikomori, R., Takada, H., Takeshita, S., Patel, N., Kim, D. S., Lheritier, K., Heike, T., Hara, T., & Yokota, S. (2013) · PubMed · Cited by 42
The GTP-Binding Domain of Class II Transactivator Regulates Its Nuclear Export
Raval, A., Weissman, J. D., Howcroft, T. K., & Singer, D. S. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.2.922 · Cited by 42
Novel genes dramatically alter regulatory network topology in amphioxus
Zhang, Q., Zmasek, C. M., Dishaw, L. J., Mueller, M. G., Ye, Y., Litman, G. W., & Godzik, A. (2008) · Genome biology · doi:10.1186/gb-2008-9-8-r123 · Cited by 40
Genetic association of NALP1 with generalized vitiligo in Jordanian Arabs
Alkhateeb, A. M., & Al‐Qarqaz, F. (2010) · Archives of Dermatological Research · doi:10.1007/s00403-010-1064-1 · Cited by 38
Polymorphisms inNLRP1gene and susceptibility to autoimmune thyroid disease
Alkhateeb, A. M., Jarun, Y., & Tashtoush, R. (2013) · Autoimmunity · doi:10.3109/08916934.2013.768617 · Cited by 37
The rs4774 CIITA missense variant is associated with risk of systemic lupus erythematosus
Bronson, P., Goldstein, B., Ramsay, P., Beckman, K. B., Noble, J., Lane, J. A., Seldin, M., Kelly, J., Harley, J., Moser, K., et al. (2011) · Genes and Immunity · doi:10.1038/gene.2011.36 · Cited by 31
Mycobacteria in Crohn’s disease: how innate immune deficiency may result in chronic inflammation
Lalande, J.-D., & Behr, M. A. (2010) · Expert Review of Clinical Immunology · doi:10.1586/eci.10.29 · Cited by 30
Mohan, M., Kaushal, D., Aye, P. P., Alvarez, X. A., Veazey, R. S., & Lackner, A. A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034561 · Cited by 27
Gyllenberg, A., Asad, S., Piehl, F., Swanberg, M., Padyukov, L., Yserloo, B. V., Rutledge, E. A., McNeney, B., Graham, J., Orho‐Melander, M., et al. (2012) · Genes and Immunity · doi:10.1038/gene.2012.44 · Cited by 27
Inhibition of Pyk2 Blocks Airway Inflammation and Hyperresponsiveness in a Mouse Model of Asthma
Duan, Y., Learoyd, J., Meliton, A. Y., Clay, B. S., Leff, A. R., & Zhu, X. (2009) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2008-0469oc · Cited by 27
Rare inborn errors associated with chronic hepatitis B virus infection
Zhao, Q., Peng, L., Huang, W., Li, Q., Pei, Y., Yuan, P., Zheng, L., Zhang, Y., Deng, J., Zhong, C., et al. (2012) · Hepatology · doi:10.1002/hep.25850 · Cited by 26
Harrison, P., Pointon, J. J., Farrar, C., Harin, A., & Wordsworth, B. P. (2006) · Lara D. Veeken · doi:10.1093/rheumatology/kel300 · Cited by 26
Swanberg, M., McGuigan, F. E., Ivaska, K. K., Gerdhem, P., & Åkesson, K. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047964 · Cited by 23
HTR1A a Novel Type 1 Diabetes Susceptibility Gene on Chromosome 5p13-q13
Asad, S., Nikamo, P., Gyllenberg, A., Bennet, H., Hansson, O., Wierup, N., Diabetes Incidence in Sweden Study Group, Carlsson, A., Forsander, G., Ivarsson, S.-A., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035439 · Cited by 22
Exome sequencing in a family segregating for celiac disease
Szperl, A., Ricaño-Ponce, I., Li, J., Deelen, P., Kanterakis, A., Plagnol, V., van Dijk, F., Westra, H.-J., Trynka, G., Mulder, C. J. J., et al. (2011) · Clinical Genetics · doi:10.1111/j.1399-0004.2011.01714.x · Cited by 19
CIITA is not associated with risk of developing rheumatoid arthritis
Bronson, P. G., Ramsay, P. P., Seldin, M. F., Gregersen, P. K., Criswell, L. A., & Barcellos, L. F. (2011) · Genes and Immunity · doi:10.1038/gene.2010.67 · Cited by 10
(2014) · Institutional Repository University of Antioquia (University of Antioquia) · doi:10.1371/journal.pone
Cited by
NLRP3 inflammasome and its inhibitors: a review
Shao, B.-Z., Xu, Z.-Q., Han, B.-Z., Su, D.-F., & Liu, C. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00262 · Cited by 836
“Formation of the inflammasome also triggers a process of inflammation-related cell death termed pyroptosis (Willingham et al., 2009; Schroder and Tschopp, 2010; Zhong et al., 2013a; Jorgensen and Miao, 2015).”
BackgroundInfluentialPharmacological Inhibitors of the NLRP3 Inflammasome
Zahid, A., Li, B., Kombe, A. J. K., Jin, T., & Tao, J. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02538 · Cited by 671
NOD-Like Receptors in Infection, Immunity, and Diseases
Kim, Y. K., Shin, J.-S., & Nahm, M. H. (2016) · Yonsei Medical Journal · doi:10.3349/ymj.2016.57.1.5 · Cited by 463
Innate immunity in diabetes and diabetic nephropathy
Wada, J., & Makino, H. (2016) · Nature Reviews Nephrology · doi:10.1038/nrneph.2015.175 · Cited by 427
Role of the NLRP3 inflammasome in cancer
Moossavi, M., Parsamanesh, N., Bahrami, A., Atkin, S. L., & Sahebkar, A. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0900-3 · Cited by 417
Metadata
- Authors
- Zhong, Y., Kinio, A., & Saleh, M.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2013
- Volume
- 4
- Pages
- 333-333
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W2169267616
- Cited by
- 317
- References
- 248
- FWCI
- 7.80
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.